Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
Advances in Experimental Medicine and Biology · 2022
DOI: 10.1007/5584_2022_748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Experimental Medicine and Biology, 2022. Verfasst von Özge Boyacıoğlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Graduate School of Science and Engineering, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Cannabinoids, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 233 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Graduate School of Science and Engineering, Hacettepe University, Ankara, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Atılım University, Ankara, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. petek@hacettepe.edu.tr.
Zitieren
APA
Boyacıoğlu, Ö., & Korkusuz, P. (2022). Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells. Advances in Experimental Medicine and Biology. https://doi.org/10.1007/5584_2022_748
Vancouver
Boyacıoğlu Ö, Korkusuz P. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells. Advances in Experimental Medicine and Biology. 2022. doi:10.1007/5584_2022_748
BibTeX
@article{Boyacolu2022,
author = {Boyacıoğlu, Özge and Korkusuz, Petek},
title = {Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells},
journal = {Advances in Experimental Medicine and Biology},
year = {2022},
doi = {10.1007/5584_2022_748}
}
EUVIMED